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Letter to the editorTwo cases of mother-to-child transmission of HIV and
Trypanosoma cruzi in ArgentinaDear Editor,
Since numerous tropical pathogens lead to opportunistic
infections in the context of the human immunodeﬁciency
virus (HIV), coinfection could have signiﬁcant effects on the
course of HIV infection.1
In this article we report two cases coinfected with HIV and
Trypanosoma cruzi presenting unfavorable evolution despite
correct treatment. Both patients were infected with both
pathogens by mother-to-child transmission (MTCT) route, and
both died due to a Klebsiella pneumoniae sepsis.
Case 1: Child 1 was admitted to the Central Children’s Hos-
pital in La Plata at age 1 month with respiratory difﬁculty
and diarrhea. The patient was a preterm newborn with good
weight for the gestational age, with no prenatal care. Both
parents were illiterate, and were living with HIV for a year
butwithout treatment, includingduring pregnancy. The father
was an intravenous drug abuser, and had been incarcerated;
a 2- year-old brother was HIV-negative but an elder sister
had died ofHIV/acquired immunodeﬁciency syndrome (AIDS).
Chagas infection in the mother was probably congenital, since
her mother emigrated from a high endemic zone. The child
presented severe malnutrition and congenital heart disease
(interventricular communication).
The child started with shortness of breath and diar-
rhea with a 48-hour evolution, and also presented bilateral
inguinal and cervical micropoliadenopaty, splenomegaly,
thrush, hypoxemia, and opisthotonus position. Disturbances
in the cerebrospinal ﬂuid cell count became apparent and
Streptococcus pneumoniae was cultivated. Therefore, the patient
was received ceftriaxone at appropriate doses for meningitis
treatment for ten days, and an erythrocyte transfusion was
performed. Vaccination with DPT-HB-Hib and Salk was indi-
cated. During hospitalization, he presented two episodes of
seizures related with fever. Serologies for several pathogens
were performed, and antibodies for T. cruzi, Toxoplasma gondii,
Epstein-Barr virus (EBV), and HIV were detected. HIV infection
was conﬁrmed by polymerase chain reaction (PCR), and T. cruzi
infection, by Microstrout (both infections were conﬁrmed in
at least two separate samples). Electroencephalography (EEG)and cerebral computed tomography (CT) were abnormal, with
muscular hypertonia and opisthostonus, both bilateral clonus
and positive Babinsky. The symptoms were interpreted as
brain damage due to pneumococcocal meningoencephalitis.
At the age of six months, he was released after 155 days
in hospital. Then, at the age of 22 months, he presented with
diarrhea and sepsis by K. pneumoniae with secondary dehydra-
tion. The patient died ten days later; he had been treated with
zidovudine since delivery and for two months with combined
HAART (lamivudine, stavudine, nelﬁnavir) and benzonidazol.
Three resistance tests were performed: two of them showed
full sensitivity,while the second test showed lamivudine resis-
tance (Fig. 1).
Case 2: Child 2 was admitted twice at a provincial hospi-
tal presenting fever with pneumonia, thrush, and anaemia,
and was later referred to the Central Children’s Hospital. The
patient had been born by normal vaginal delivery, without
complications, after a full-termgestation. Hismother, aged 33,
from Paraguay, had received prenatal care; her serology was
positive for both HIV and for Chagas disease. His father was
also HIV-infected. The mother was treated with lamivudine
and nevirapine from the age of 17 and received zidovudine
late in her pregnancy. In the last admission, the child had
an unfavorable evolution with hepatitis and progressive liver
failure. Serologies were positive for T. cruzi, cytomegalovirus
(CMV), and HIV. HIV infection was conﬁrmed by PCR, and T.
cruzi infection, by Microstrout (both infections were conﬁrmed
in at least two separate samples). Treatment with zidovudine,
nevirapine, and lamivudine was started.
The child received zidovudine for the ﬁrst six weeks and
was treated with interrupted HAART after three months due
to severe organic failure. After 39 days at the ICU, the child
died with sepsis by K. pneumoniae.
Data from HIV and T. cruzi coinfected patients indicated
reactivation of the parasite infection with exacerbation of
clinical signs and unusual clinical manifestations,2 as well
3–5as MTCT with severe outcome for the child. In the two
presented cases, there was a clear loss of opportunities for
prevention of HIV MTCT. Despite the provision of treatment
and free follow-up provided by the government, effective
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Fig. 1 – Timepoints for results for HIV and Trypanosoma cruzi tests, hospital admissions, treatment, resistance tests for HIV,
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ntiretroviral (ARV) treatment did not reach these two moth-
rs. In Case 1, this was probably due to the social status of the
arents, who did not receive any ARV treatment; in Case 2,
RV treatment might have been insufﬁcient with only ZDV in
he last trimester. The oldest sibling of Case 1 may have also
ied of undiagnosed coinfection. Further, T. cruzi infection
as not diagnosed by the physicians working in the provincial
ospital in Case 2. This delay in the treatment, initiated only
t the Children’s Hospital, may have further compromised
he course of coinfection.
onﬂict of interest
ll authors declare to have no conﬂict of interest.
cknowledgements
his research has been partially funded by a Fogarty Interna-
ional Center/NIH grant through the AIDS International Train-
ng and Research Program at Mount Sinai School of Medicine -
rgentina Program (Grant # 5D43TW0010137), andgrants from
he Universidad de Buenos Aires (M043) to Liliana Martínez
eralta. This study was approved by the Independent Ethics
ommittee, School of Medicine, Universidad de Buenos Aires.
e f e r e n c e s
. Karp CL, Auwaerter PG. Coinfection with HIV and tropical
infectious diseases. I. Protozoal pathogens. Clin Infect Dis.
2007;45:1208–13.
. Cordova E, Boschi A, Ambrosioni J, et al. Reactivation of Chagas
disease with central nervous system involvement in.
HIV-infected patients in Argentina, 1992-2007. Int J Infect Dis.
2008;12:587–92.
. Freilij H, Altcheh J. Congenital Chagas’ disease: diagnostic and
clinical aspects. Clin Infect Dis. 1995;21:551–5.
. Nisida IV, Amato Neto V, Braz LM, et al. A survey of congenital
Chagas’ disease, carried out at three health institutions in
Sao Paulo City, Brazil. Rev Inst Med Trop Sao Paulo.
1999;41:305–11.
. Gurtler RE, Segura EL, Cohen JE. Congenital transmission of
Trypanosoma cruzi infection in Argentina. Emerg Infect Dis.
2003;9:29–32.
Maria Rosa Agosti
Sor María Ludovica Children’s Hospital, La Plata
Pablo Ercoli, Guillermina Dolcini,
Guadalupe Andreani, Liliana Martínez Peralta ∗
National Reference Center for AIDS, Department of Microbiology,
Universidad de Buenos Aires School of Medicine, Buenos Aires
Silvia González Ayala
Sor María Ludovica Children’s Hospital, La Plata
∗ Corresponding author at: Universidad de Buenos Aires, School
of Medicine, Paraguay 2155, Buenos Aires, C1121ABG,
Argentina.
E-mail address: lilimp@fmed.uba.ar (L. Martínez Peralta).
15 November 2011
22 November 2011
1413-8670http://dx.doi.org/10.1016/j.bjid.2012.06.008
© 2012 Elsevier Editora Ltda.
 Este é um artigo Open Access sob a licença de CC BY-NC-ND
